Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid CancerNew England Journal of MedicineFebruary 11, 201510.1056/nejmoa1406470Cited by 2,071SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis